GILD
Stock Details
GILD is Gilead Sciences, Inc.'s stock. Stock exchange NasdaqGS (Currency USD). Average price in 50 days is 82.12$. Average daily volumn in 3 months 6.25M. Market cap 103.61B
Stock symbol : GILD. Exchange : NasdaqGS. Currency : USD Lastest price : 82.97$. Total volume : 7.14M. Market state CLOSED Click reload if you want to check the lastest price on market!!!
Gilead Sciences, Inc. (GILD)
Last Price
82.97$Change
1.52Volume
7.14M
| Previous Close | 81.45 |
| Open | 81.64 |
| Day Range | 81.19-83.14 |
| Bid | 82.86 x 1.1k |
| Ask | 83.00 x 900 |
| Volume | 7.14M |
| Average Volume | 6.25M |
| Market Cap | 103.61B |
| Beta | 0.40 |
| 52 Week Range | 57.17-89.74 |
| Trailing P/E | 22.79 |
| Foward P/E | 11.49 |
| Dividend (Yield %) | 3.62% |
| Ex-Dividend Date | 2023-03-14 |
Financial Details
Organization
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of vi... ral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Market Cap:
103.61BRevenue:
27.28BTotal Assets:
63.17BTotal Cash:
5.41B
News about "Gilead Sciences, Inc."
Is Gilead Sciences, Inc.'s (NASDAQ:GILD) 22% ROE Strong Compared To Its Industry?
Source from : YAHOO!Finance - 8 hours ago
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article ...See details»
Gilead Sciences Inc. (NASDAQ:GILD) Jumps 1.87%, But Additional Rally May Be Imminent
Source from : marketingsentinel - 1 days ago
In last trading session, Gilead Sciences Inc. (NASDAQ:GILD) saw 7.13 million shares changing hands with its beta currently measuring 0.40. Company’s recent per share price level of $82.97 trading at ...See details»
Gilead Sciences Inc. stock outperforms market on strong trading day
Source from : MarketWatch - 4 days ago
Shares of Gilead Sciences Inc. advanced 1.75% to $80.97 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the ...See details»
Gilead Sciences
Source from : CSR Wire - 3 days ago
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform ...See details»
GILD Gilead Sciences, Inc.
Source from : Seeking Alpha - 2 days ago
**NM signifies a non meaningful value. A dash signifies the data is not available.See details»
Gilead Sciences Inc. (GILD) Stock: What the Analysts are Saying
Source from : newsheater - 9 days ago
Gilead Sciences Inc. (NASDAQ: GILD) has a price-to-earnings ratio that is above its average at 21.65x. and a 36-month beta value of 0.40. Opinions on the stock are mixed, with 9 analysts rating it as ...See details»
Gilead Sciences, Inc. (NASDAQ:GILD) is a favorite amongst institutional investors who own 84%
Source from : Yahoo Finance - 21 days ago
We note that hedge funds don't have a meaningful investment in Gilead Sciences. BlackRock, Inc. is currently the company's largest shareholder with 11% of shares outstanding. For context ...See details»
Gilead Sciences Inc. (GILD) Stock: A Guide to the Market Trend
Source from : newsheater - 12 days ago
The stock of Gilead Sciences Inc. (GILD) has seen a -0.06% decrease in the past week, with a -4.71% drop in the past month, and a -8.22% decrease in the past quarter. The volatility ratio for the week ...See details»
Gilead Sciences Inc. stock underperforms Wednesday when compared to competitors
Source from : MarketWatch - 17 days ago
Shares of Gilead Sciences Inc. GILD slid 0.15% to $79.65 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.70% to 3,891. ...See details»
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Could Be 40% Below Their Intrinsic Value Estimate
Source from : Yahoo - 3 month ago
Today we will run through one way of estimating the intrinsic value of Gilead Sciences, Inc. (NASDAQ:GILD) by taking the expected future cash flows and discounting them to today's value.See details»
What Contributed to Gilead Sciences (GILD)’s Outperformance in Q4?
Source from : Yahoo - 27 days ago
ClearBridge Sustainability Leaders Strategy highlighted stocks like Gilead Sciences, Inc. (NASDAQ:GILD) in the Q4 2022 investor letter. Headquartered in Foster City, California, Gilead Sciences ...See details»
Gilead Sciences Inc
Source from : Reuters - 17 days ago
2023 Future of Healthcategory GSK's ViiV says study shows its long-acting HIV shot as effective as Gilead's daily pill, article with image February 22, 2023 Worldcategory Britain's NICE to speed ...See details»
Gilead Sciences, Inc.
Source from : Fierce Healthcare - 1 month ago
For 35 years, Gilead has been a leading innovator in the field of HIV, driving advances in treatment, prevention and cure research. Gilead researchers have developed 12 HIV medications ...See details»
Gilead Sciences Inc. News
Source from : TheStreet.com - 6 days ago
Add this cloud software stock to your watch list, but it may be a good time to take some profit in this biotech stock and industrial stock.See details»